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ABSTRACT
miRandola (http://mirandola.iit.cnr.it/) is a database
of extracellular non-coding RNAs (ncRNAs) that was
initially published in 2012, foreseeing the relevance
of ncRNAs as non-invasive biomarkers. An increas-
ing amount of experimental evidence shows that
ncRNAs are frequently dysregulated in diseases.
Further, ncRNAs have been discovered in differ-
ent extracellular forms, such as exosomes, which
circulate in human body fluids. Thus, miRandola
2017 is an effort to update and collect the accumu-
lating information on extracellular ncRNAs that is
spread across scientific publications and different
databases. Data are manually curated from 314 arti-
cles that describe miRNAs, long non-coding RNAs
and circular RNAs. Fourteen organisms are now in-
cluded in the database, and associations of ncRNAs
with 25 drugs, 47 sample types and 197 diseases.
miRandola also classifies extracellular RNAs based
on their extracellular form: Argonaute2 protein, ex-
osome, microvesicle, microparticle, membrane vesi-
cle, high density lipoprotein and circulating. We also
implemented a new web interface to improve the user
experience.
INTRODUCTION
miRNAs are small non-coding RNAs (ncRNAs) (21–
23 nt long) that regulate gene expression at the post-
transcriptional level by binding to messenger RNAs (mR-
NAs) and inhibiting their translation into proteins or by
binding to other ncRNAs (1).
First discovered in 1993 in Caenorhabditis elegans (2),
miRNAs had tremendous impact on the study of gene ex-
pression regulation and regulatory networks. Since their
discovery as post-transcriptional regulators (3), specific
links have been discovered between miRNA and human
pathologies (4–7), and further studies indicate the utility of
some miRNAs as biomarkers for cancer and other diseases
(5). Some miRNA-targeted therapeutics have been tested
in clinical trials, including a miRNA mimic of the tumor
suppressor miR-34, which reached phase I clinical trials for
treating cancer, and antimiRs for miR-122, which reached
phase II trials for treating hepatitis (8).
Recently, miRNAs were shown to be present in human
body fluids (9), resulting in the potential use of these small
RNAs as non-invasive biomarkers (9,10). The great poten-
tial of extracellular miRNAs as biomarkers is their high sta-
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Figure 1. Descriptive statistics of the database. (A) Number of RNAs across RNA classes; (B) Number of RNAs across extracellular RNA forms.
Table 1. Comparison between the latest 2017 version and the previous version of miRandola
Previous version miRandola 2017
*Papers 119 314
Entries 2276 3283
microRNAs 590 1002
lncRNAs 0 12
CircRNAs 0 8
Extracellular RNA forms 4 7
Drugs 6 25
Organisms 1 14
Sample types 23 47
Visualization tool No Yes
External data ExoCarta ExoCarta and Vesiclepedia
**Text-mining-assisted curation No Yes
*See the supplementary table.
**See the manuscript for more details.
bility in plasma, serum, saliva, urine and many other fluids
(9–12). This stability is due to the formation of complexes
of extracellular miRNAs in membrane-bound vesicles such
as exosomes, which offers them protection from RNAses
(13,14). Moreover, miRNAs can be found complexed with
the Argonaute2 (Ago2) protein, part of the RNA-induced
silencing complex (RISC) responsible of the RNA silenc-
ing mediated by miRNAs (15,16). miRNAs also complex
with high density lipoprotein (HDL) (17), which provides
the mechanism for a new pathway for intercellular commu-
nication. In fact, miRNAs transported by HDL can be de-
livered to recipient cells, where they can alter the expression
of their targets (17).
Given the rising interest in miRNAs and more generally
other ncRNAs as potential biomarkers, we present an up-
dated version of the miRandola database (11,12), with ex-
tensive addition of curated publications, new visualizations
and additional functionality in the web interface.
DATA COLLECTION AND CONTENT
The majority of the data were extracted from the liter-
ature in PubMed (https://www.ncbi.nlm.nih.gov/pubmed).
This included information regarding: the RNA type, sam-
ple type, experimental procedures, associated diseases, ex-
tracellular RNA forms and other metadata regarding pub-
lications, including a summary of the results of the study.
Some articles were collected from two publicly available re-
sources, ExoCarta (18) and Vesiclepedia (19), which are two
manually curated databases specialized in collecting infor-
mation on extracellular vesicles.
The first version of the database made use of human
biocurators that searched in PubMed using several key-
words such as ‘microRNA’, ‘circulating’ and ‘extracellular’
and then manually extracted the relevant information. For
this new version, we introduced text-mining-assisted cura-
tion to identify and prioritize papers for manual curation.
The text mining approach will help our internal curators
to increase the update frequency of the database to at least
twice a year.
To identify terms of interest, the text-mining software
uses dictionaries of human ncRNAs (20), diseases (21) and
keywords that indicate extracellular RNA forms. We per-
formed the text mining on more than 26 million entries in
PubMed using the tagger software (22). We scored pairs of
these terms by summing scores for all co-occurrences of the
terms in the same sentence, paragraph and abstract with de-
creasing weights. We then normalized these scores, and we
calculated the geometric mean of RNA-disease and RNA-
circulating scores, which we took as the final score for the
combined association between circulating RNA and dis-
ease. Scientific articles that contain all three types of terms
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Figure 2. Results table containing the core information of the database. In this example, we report one result for hsa-miR-21.
were given the same score as the triple (RNA-extracellular
form-disease). Scores were then used to rank articles and
facilitate the manual curation.
Altogether, the collected data consisted of 314 articles
(see Supplementary Table and website), a notably higher
number of papers compared with the first version of the
database (n = 89) (12) and the previous short update (n =
119) (11). For details on the database content see Table 1.
The database aims to present a comprehensive list of all
known extracellular ncRNAs. Still, the majority of studies
included in this version of miRandola focus on extracellu-
lar miRNAs, since they are the most investigated type of
ncRNA. Although, in this new version, we started to collect
information on two new RNA classes, namely long ncR-
NAs (lncRNAs) of more than 200 nt, and circular RNAs
(circRNAs), which are transcripts that form a continuous
loop. These RNA classes represent a small portion of the
entries in the database (counts are reported in Table 1 and
Figure 1A) and future updates will introduce additional
information. Figure 1B shows the variety of extracellular
forms that the ncRNAs are found complexed with, includ-
ing Ago2, exosomes and HDL. More than 35% of RNAs
have been annotated only as ‘circulating’, indicating that
authors did not specify whether the RNA was complexed
with known extracellular forms (Figure 1B).
Recently, some well-known extracellular lncRNAs have
been used as potential non-invasive biomarkers. Probably
the most famous example is PCA3 (also known as DD3),
which is highly overexpressed in most types of prostate can-
cer cells and detectable in urine (23). This new non-invasive
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Figure 3. Circos plot of the most representative tumor types in the database. The plot shows how many RNAs are shared by different tumors.
biomarker shows great potential to improve patient care by
reducing the number of biopsies (23).
The function of circRNAs is largely unknown, but some
studies have shown that they are able to act as a natural
‘sponge’, by binding and down-regulatingmiRNAs (24,25).
Since circRNAs are stable molecules (26), they have been
proposed as novel non-invasive biomarker candidates (26).
DATABASE DEVELOPMENT AND WEB INTERFACE
Data were collected and are maintained in a MySQL
database running on an Apache server. The redesigned web
interface was implemented using PHP and JavaScript (via
the libraries AngularJS andD3.js). Furthermore, Bootstrap
is used as front-end framework for faster and easier web
development, allowing compatibility with web browsers. In
this new version of the database we implemented new func-
tionalities to explore and visualize data making the website
more dynamic.
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Starting from the home page of the database (see Sup-
plementary Figure S1A), users can quickly search for the
name of the RNA of interest by typing it into a search bar.
We have implemented an autocomplete function in order to
facilitate the search (see Supplementary Figure S1B). After
clicking on the RNA of interest, users will have an overview
of the extracellular forms inwhich theRNAhas been found,
and are able to click on the specific term to browse the re-
sults.
The user can browse by the following data types (see Sup-
plementary Figure S2A): ‘miRNAs’, ‘lncRNAs’, ‘circR-
NAs’, ‘Diseases’, ‘exRNA forms’, ‘Samples’, ‘Drugs’ and
‘Organisms’. For instance, after clicking on ‘miRNAs’, a
summary table will be shown (see Supplementary Figure
S2B) with miRNA identifiers as reported in literature, but
also with the official miRNA identifiers annotated in the
last version of the miRNA registry miRBase (27).
Each table can be filtered on a term of interest (see Sup-
plementary Figure S2B), and can also be sorted. After click-
ing on a specificRNAof interest (see Supplementary Figure
S2C and B), a results table is displayed (Figure 2).
The results table contains annotations specific to the se-
lected RNA and other details such as publication identifier,
reporting title, publication year, first author and journal.We
show associations to diseases, sample types, the extracellu-
lar RNA type, the RNA expression level and the drug used
in the experiment. We also report the methods used to ver-
ify the expression or other relevant techniques, and a short
description of the results. The results table contains a field
called ‘Potential biomarker role defined in the article’, indi-
cating whether the selected RNA has a potential role as a
biomarker, as stated in the published article.
Users can also use the ‘Search’ section (see Supplemen-
tary Figure S3) to search for pairs of terms such as ‘hsa-
miR-21’ and ‘non-small cell lung cancer’.
All the data inmiRandola are available in the ‘Download’
section of the database.
VISUALIZATION
In this new version of miRandola, we introduce a visu-
alization to show RNA-disease co-occurrences extracted
from literature, and a circos plot (Figure 3) that shows how
many RNAs are shared between the most representative tu-
mor types in our database. This plot reveals that most tu-
mors share several extracellular RNAs, with the exception
of ‘Cervical squamous cell carcinoma’ for which we have
no evidence of RNAs that are shared with any of the other
tumor types. This common signature can be used to help
identify common non-invasive biomarkers for many types
of cancer.
FUTURE PERSPECTIVE
When the field of extracellular RNAs was still new, miRan-
dola was started as a small project and it soon became a
successful database due to the work of a few biocurators
and developers. In this new version, the involvement of ad-
ditional biocurators and the introduction of assisted cura-
tion using text mining both contributed to the collection of
many more curated articles, and on an ongoing basis, im-
proves our ability to update the database regularly. We em-
phasize manual curation as an indispensable step, and de-
fine it as the fingerprint of miRandola. For this reason, we
will evaluate the participation of the scientific community in
the curation process in future updates. We aim to develop a
new online tool to achieve this goal, giving users the possi-
bility to curate articles that have been identified and prior-
itized by text mining. After this step, our internal curators
will verify the information introduced by the scientific com-
munity.
The final goal of miRandola is to be a reference database
for all non-invasive biomarkers, and future updates will
consider other data such as extracellular DNA, giving a
comprehensive panel of disease-specific biomarkers.
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miRandola is available at http://mirandola.iit.cnr.it/.
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Supplementary Data are available at NAR Online.
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